You just read:

Information Update - Clinical trial finds an increased risk of blood clots in the lungs and of death in rheumatoid arthritis patients taking high dose of tofacitinib (sold as Xeljanz or Xeljanz XR)

News provided by

Health Canada

Mar 15, 2019, 17:01 ET